Inflammatory Biomarkers and Cardiovascular Risk
Ridker PM • J Am Coll Cardiol • 2007
hsCRP independently predicts myocardial infarction, stroke, diabetes, and all-cause mortality
The research behind Metabolicum's evidence-based approach
Not all research is equal. We assign confidence grades to each source based on study design, sample size, replication status, and methodology. This helps you understand how confident you can be in each finding.
High Confidence
Replicated findings across multiple well-designed studies
Good Confidence
Well-designed single studies with strong methodology
Moderate Confidence
Observational data with consistent patterns
Emerging Evidence
Mechanistic or theoretical - interpret cautiously
Clinical Consensus
Practitioner experience without formal trials
Why are we so careful about evidence grading? Because a significant portion of published research fails to replicate.
| Study | Finding | Grade |
|---|---|---|
| Begley & Ellis, 2012 | Only 21% of landmark cancer studies could be replicated | A |
| Open Science Collaboration, 2015 | Only 36% of psychology studies replicated | A |
| Ioannidis, 2005 | Theoretical framework explaining why most findings are false | A |
This doesn't mean you should distrust all research. It means:
We grade evidence honestly so you can calibrate your confidence appropriately.
In-depth analysis of foundational studies with translated summaries
Showing 10 studies
Ridker PM • J Am Coll Cardiol • 2007
hsCRP independently predicts myocardial infarction, stroke, diabetes, and all-cause mortality
Ridker PM, Danielson E, Fonseca FA, et al. • N Engl J Med • 2008
Statin therapy reduces cardiovascular events by 44% in people with elevated CRP and normal LDL
Pearson TA, Mensah GA, Alexander RW, et al. • Circulation • 2003
AHA/CDC endorses hsCRP for cardiovascular risk stratification in intermediate-risk patients
Emerging Risk Factors Collaboration • Lancet • 2010
Per 3-fold higher CRP: CHD HR 1.37 (1.27-1.48), ischaemic stroke HR 1.27 (1.15-1.40), vascular mortality HR 1.55 (1.37-1.76) after adjustment
Calder PC • Nutrients • 2010
Effective anti-inflammatory effects require >2g EPA+DHA daily; EPA-derived eicosanoids 10-100 fold less potent as inflammatory mediators; new steady-state reached within ~4 weeks
Irwin MR, et al • Biological Psychiatry • 2016
Sleep disturbance associated with elevated CRP (effect size 0.12) and IL-6 (effect size 0.20); long sleep duration associated with higher CRP (effect size 0.17)
Esposito K, Marfella R, Ciotola M, et al. • JAMA • 2004
Mediterranean diet significantly reduces hsCRP and other inflammatory markers
Forsythe CE, Phinney SD, Fernandez ML, et al. • Lipids • 2008
Low-carbohydrate diets may reduce inflammatory markers more effectively than low-fat diets
Selvin E, Paynter NP, Erlinger TP • Arch Intern Med • 2007
Weight loss reduces CRP levels proportionally to the degree of weight lost
Minihane AM, et al • British Journal of Nutrition • 2015
An unresolved inflammatory response is likely involved from early stages of disease development; current fasting inflammatory markers represent an insensitive and highly variable index of tissue inflammation
Primary thresholds come from Grade A sources. When Grade A evidence suggests a range rather than a single value, we present the range with context.
We draw on Grades A-C for educational claims, clearly labeling evidence quality. Grade D and E content is marked as theoretical or practitioner-derived.
This bibliography contains the research supporting Metabolicum's evidence-based approach.
Last comprehensive review: December 2025